Myungmoon Phar (017180) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.005x

Based on the latest financial reports, Myungmoon Phar (017180) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩519.72 Million ≈ $352.20K USD) by net assets (₩104.46 Billion ≈ $70.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 017180 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Myungmoon Phar - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Myungmoon Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Myungmoon Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Myungmoon Phar ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gurktaler AG ST VI:GAGS	-0.006x
PJP Makrum S.A. WAR:PJP	0.078x
Chin Yang Chem KO:051630	0.009x
K2A Knaust & Andersson Fastigheter AB (publ) ST:K2A-B	-0.007x
Dongil Technology Ltd KQ:032960	0.011x
Sapmer PA:ALMER	0.004x
Tubos Reunidos S.A MC:TRG	0.523x
Powercom Co Ltd TW:3043	-0.300x

Annual Cash Flow Conversion Efficiency for Myungmoon Phar (2010–2025)

The table below shows the annual cash flow conversion efficiency of Myungmoon Phar from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Myungmoon Phar.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩104.46 Billion ≈ $70.79 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.016x	-25.76%
2024-12-31	₩103.12 Billion ≈ $69.88 Million	₩-1.34 Billion ≈ $-906.54K	-0.013x	+77.78%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	₩-5.18 Billion ≈ $-3.51 Million	-0.058x	-201.57%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	₩5.47 Billion ≈ $3.71 Million	0.057x	+477.20%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	₩855.00 Million ≈ $579.42K	0.010x	+105.42%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	₩-16.67 Billion ≈ $-11.30 Million	-0.184x	-400.89%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	₩-2.94 Billion ≈ $-1.99 Million	-0.037x	-129.92%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	₩11.41 Billion ≈ $7.73 Million	0.123x	+55.39%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	₩8.02 Billion ≈ $5.44 Million	0.079x	+33.34%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	₩5.60 Billion ≈ $3.80 Million	0.059x	+172.13%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.082x	-16457.33%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	₩-36.23 Million ≈ $-24.56K	0.000x	-101.81%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	₩2.00 Billion ≈ $1.36 Million	0.027x	-28.27%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	₩2.78 Billion ≈ $1.88 Million	0.038x	-10.77%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	₩2.87 Billion ≈ $1.95 Million	0.043x	--

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$29.29 Million

₩43.22 Billion KRW

Market Cap Rank

#23893 Global

#1639 in Korea

Share Price

₩1273.00

Change (1 day)

-3.56%

52-Week Range

₩1267.00 - ₩1945.00

All Time High

₩10277.86